Pharmaceuticals
Merck & Co to sell consumer care business to Germany's Bayer for $14.2 bn
06 May 2014
The deal, which will make Bayer the second-biggest over-the-counter drugs (OTC) maker after Johnson & Johnson, is the largest in the German healthcare industry after Bayer outbid Merck to acquire Schering in 2006 for $21.5 billion
Sterigenics raises bid for Canadian isotope supplier Nordion to $758 mn
06 May 2014
Nordion is one of the world's leading producers of molybdenum-99, an isotope used in medical imaging and a leading provider of sterilisation technologies and medical isotopes used for the prevention, diagnosis and treatment of diseases
Cable admits Pfizer-AstaraZeneca deal involves ‘national interest’ issues
05 May 2014
Britain’s Business Secretary Vince Cable said late on Sunday that the bid by Pfizer Inc for AstraZeneca Plc raised questions of “overriding national interest”, as the opposition Labour Party stepped up its campaign against the proposed takeover
AstraZeneca rejects Pfizer’s revised $106 billion offer
02 May 2014
Today’s 50 pounds ($84.47) a share indicative offer followed AstraZeneca's decision to reject an earlier proposal that valued it at 46.61 pounds per share
AstraZeneca to consider Pfizer’s $106-bn bid
02 May 2014
The announcement comes just days after AstraZeneca Plc denied plans to discuss any partnership proposals with Pfizer
Bayer offers to swap cash and animal health unit for Merck's consumer healthcare
30 Apr 2014
German healthcare major Bayer AG has offered to swap its animal health unit and also pay some cash in exchange for Merck & Co's consumer healthcare business
HC blocks Ranbaxy-Sun Pharma merger over insider trading allegations
30 Apr 2014
The order was in response to a petition for a Sebi inquiry into possible insider trading in Ranbaxy shares that saw heavy trading before the merger with Sun Pharma was announced
